Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-03 Sale | 2024-10-03 9:55 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 6,272 | $0.55 | $3,450 | 19,011 (Direct) | View |
| 2024-09-16 Sale | 2024-09-17 7:18 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 215 | $0.6908 | $149 | 11,533 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 9:26 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 244 | $1.2627 | $308 | 11,748 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:31 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 1,008 | $2.6351 | $2,656 | 11,992 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-17 Option Award | 2024-10-03 9:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 21,250 | $0 | 19,011 (Direct) | View |
| 2024-09-15 Exercise | 2024-09-17 7:18 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,533 (Direct) | View |
| 2024-06-15 Exercise(A) | 2024-09-17 7:17 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 8,250 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-18 9:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer | 750 | $0 | 11,748 (Direct) | View |
| 2024-03-15 Exercise | 2024-04-08 7:31 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 3,000 | $0 | 11,992 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:58 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-01-17 Option Award | 2022-01-19 4:19 pm | N/A 2032-01-16 | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 4:36 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 5,151 | $3.51 | 109,246 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 12:15 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 2,573 | $6.84 | 114,397 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 4:40 pm | N/A 2031-02-22 | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 92,250 | $0 | 181,545 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 1,541 | $1.58 | 357,181 (Direct) | View |
| 2020-11-30 Option Award | 2020-12-02 4:31 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 7,838 | $1.445 | 358,722 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 4:32 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer | 1,541 | $1.66 | 350,884 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 4:25 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 1,541 | $1.73 | 352,425 (Direct) | View |
| 2020-05-06 Option Award | 2020-05-08 5:54 pm | N/A 2030-05-06 | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 150,000 | $0 | 503,967 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 5:23 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 137,824 | $0 | 203,967 (Direct) | View |
| 2020-04-06 Tax Withholding | 2020-04-07 5:23 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 908 | $1.4 | 203,967 (Direct) | View |
| 2020-03-31 Tax Withholding | 2020-04-02 4:41 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 525 | $2.68 | 67,051 (Direct) | View |
| 2020-03-09 Option Award | 2020-03-11 5:57 pm | N/A 2028-12-03 | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 183,902 | $0 | 183,902 (Direct) | View |
Ownership | 2020-03-11 5:53 pm | N/A N/A | Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer | 0 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2028-12-03 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 310,439 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 1,993 | $2.6775 | 114,074 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 137,664 | $0 | 208,446 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:24 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 2,500 | $3.28 | 70,782 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-03 4:31 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 9,842 | $2.159 | 73,282 (Direct) | View |